Literature DB >> 30311466

Adult onset xanthogranuloma associated with IgG4-related disease.

Kai Ching Peter Leung1, Philip Ko2, Chun Ho Jonathan Ho3, Tak Chuen Simon Ko3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30311466      PMCID: PMC6182211          DOI: 10.3341/kjo.2017.0145

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


× No keyword cloud information.
  5 in total

1.  Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease.

Authors:  Kamaljeet Singh; K D A Rajan; Charles Eberhart
Journal:  Ocul Immunol Inflamm       Date:  2010-10       Impact factor: 3.070

2.  Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease.

Authors:  Wah Cheuk; Hunter K L Yuen; Alexander C L Chan; Lee-Yung Shih; Tseng-Tong Kuo; Ming-Wai Ma; Yan-Fai Lo; Wai-Kong Chan; John K C Chan
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

3.  Comparative Study of Clinical, Pathological, Radiological, and Genetic Features of Patients With Adult Ocular Adnexal Xanthogranulomatous Disease, Erdheim-Chester Disease, and IgG4-Related Disease of the Orbit/Ocular Adnexa.

Authors:  Penelope McKelvie; Alan A McNab; Thomas Hardy; Vivek Rathi
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 Mar/Apr       Impact factor: 1.746

4.  Adult-Onset Asthma and Periocular Xanthogranulomas Associated with Systemic IgG4-Related Disease.

Authors:  Christopher K H Burris; Maria E Rodriguez; Meisha L Raven; Cat N Burkat; Daniel M Albert
Journal:  Am J Ophthalmol Case Rep       Date:  2016-04

5.  Adult Onset Asthma and Periocular Xanthogranuloma (AAPOX), a Rare Entity With a Strong Link to IgG4-Related Disease: An Observational Case Report Study.

Authors:  Jonathan London; Antoine Martin; Michael Soussan; Isabelle Badelon; Thomas Gille; Yurdagul Uzunhan; Bénédicte Giroux-Leprieur; Ursula Warzocha; Alexis Régent; Olivier Galatoire; Robin Dhote; Sébastien Abad
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.